NEW YORK, May 31, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Provides analysis of over ten key marketed products and indentifies over 40 R&D candidates in preclinical to clinical stages of development.
Future Therapies for Birth Control and Reproductive Health
The current market for hormonal contraceptives and infertility drugs is estimated at US$9.4bn, and is forecast to increase by 7% in annual revenues to US$10bn by 2014.
In this report, The Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health (2nd Edition) the reader will be introduced to an analysis of current product markets, research and development themes, and company activities within the field.
The report provides insights for product extension and reformulation, sales forecasts to 2018, and allows for assessments of the impact of late-stage pipeline drugs on the market. An overview of R&D programs within the field is also presented showing products from preclinical to premarket authorization phases of development. Therapy area forecasting to 2018 enables the reader to make key